Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study
二肽基肽酶-4抑制剂和胰高血糖素样肽-1受体激动剂与COVID-19感染及不良预后之间的关联:一项队列研究
期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2024-004677
Thompson, Wade; Yu, Bing; Porter, Joan; Fang, Jiming; Ferreira-Legere, Laura E; Austin, Peter C; Jackevicius, Cynthia A; Ross, Heather; Lee, Douglas S; Weisman, Alanna; Farkouh, Michael E; Gershon, Andrea S; Atzema, Clare L; Kwong, Jeffrey C; Ha, Andrew; Džavík, Vladimír; Udell, Jacob A